Production (Stage)
Adicet Bio, Inc.
ACET
$0.6936
-$0.0251-3.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.34% | 8.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.79% | -7.27% | |||
| Operating Income | 2.79% | 7.27% | |||
| Income Before Tax | 1.79% | 5.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.79% | 5.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.79% | 5.75% | |||
| EBIT | 2.79% | 7.27% | |||
| EBITDA | 3.14% | 7.73% | |||
| EPS Basic | 2.02% | 5.75% | |||
| Normalized Basic EPS | 2.02% | 5.77% | |||
| EPS Diluted | 2.02% | 5.75% | |||
| Normalized Diluted EPS | 2.02% | 5.77% | |||
| Average Basic Shares Outstanding | 0.25% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.25% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||